CHRD and infiltrating bladder urothelial carcinoma: GLI1 showed a significant level of co-expression in mucinous breast carcinoma and ovarian serous surface papillary carcinoma, whereas AMHR2, CHRD, and ACVR2A showed a similar pattern in ovarian serous papillary carcinoma, superficial bladder carcinoma and infiltrating urothelial bladder carcinoma.